Stephenson Pamela 4
4 · Disc Medicine, Inc. · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Disc Medicine (IRON) CCO Pamela Stephenson Sells 5,531 Shares
What Happened
Pamela Stephenson, Chief Commercial Officer of Disc Medicine (IRON), sold 5,531 shares on February 17, 2026 at $62.86 per share, generating proceeds of $347,679. The filing classifies this as an S (sale) and the transaction was a "sell-to-cover" tied to tax withholding for the vesting of previously reported restricted stock units (RSUs), not a discretionary open-market trade.
Key Details
- Transaction date: 2026-02-17
- Price: $62.86 per share; Shares sold: 5,531; Total proceeds: $347,679
- Transaction type/code: Sale (S); described as "open market or private sale" in the filing
- Footnote: F1 — sale was to cover tax withholding on vested RSUs (non‑discretionary "sell-to-cover")
- Shares owned after transaction: Not specified in the provided filing excerpt
- Filing/timeliness: Reported on 2026-02-17 (filed same day; appears timely)
Context
A "sell-to-cover" is a routine tax-withholding sale when equity awards vest and does not necessarily reflect the insider's view of the company's prospects. For retail investors, purchases or discretionary sales are typically more informative about insider sentiment; this transaction reflects administrative tax withholding related to RSU vesting.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-02-17$62.86/sh−5,531$347,679→ 80,998 total
Footnotes (1)
- [F1]This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.